Published in J Pharm Pharmacol on May 01, 1983
Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung (1975) 2.72
The effect of indomethacin on the release of prostaglandin E2 and acetylcholine from guinea-pig isolated ileum at rest and during field stimulation. Br J Pharmacol (1974) 2.04
Pharmacology of BS 100-141, a centrally acting antihypertensive drug. Clin Exp Pharmacol Physiol (1975) 1.86
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung (1977) 1.41
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
The alkaloid sinomenine lacks efficacy in rat heart transplantation. Transpl Int (2000) 1.39
Effects of clonidine and BS 100-141 on the EEG sleep pattern in rats. Eur J Pharmacol (1975) 1.36
The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats. Am J Transplant (2008) 1.31
The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol (1985) 1.25
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis (1999) 1.12
Structure, function and pharmacology of voltage-gated sodium channels. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.12
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.11
Substituted phenylacetylguanidines: a new class of antihypertensive agents. Arzneimittelforschung (1975) 1.07
The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the cat. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.04
Treatment of a case of lanatoside C intoxication with digoxin-specific F(ab')2 antibody fragments. Am Heart J (1979) 1.00
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel. Eur J Pharmacol (1986) 0.98
[Comparative studies on the influencing of adrenergic reactions by ergotamine and dihydroergotamine in different experimental models]. Helv Physiol Pharmacol Acta (1968) 0.96
The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. J Pharmacol Exp Ther (1997) 0.96
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits. Br J Pharmacol (1975) 0.93
Digitoxin intoxication with severe thrombocytopenia: reversal by digoxin-specific antibodies. Eur J Clin Invest (1983) 0.92
Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med (2003) 0.91
Early angiographic control of perioperative ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg (2001) 0.91
Inhibition of the re-uptake of neuronally liberated noradrenaline and alpha-receptor blocking action of some ergot alkaloids. Br J Pharmacol (1970) 0.91
Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol (1991) 0.91
Cardiovascular actions of bromocriptine. Acta Endocrinol Suppl (Copenh) (1978) 0.89
Antiarrhythmic effects of DPI 201-106. Br J Pharmacol (1986) 0.87
Sprouting and nerve retraction in frog neuromuscular junction during ontogenesis and environmental changes. Neuroscience (1986) 0.86
Identification of a cardiac sodium channel insensitive to synthetic modulators. J Cardiovasc Pharmacol Ther (2001) 0.86
Proceedings: The effect of PGE1, PGE2 and PGF2alpha on parasympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.86
5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist. J Vet Pharmacol Ther (2002) 0.86
Proceedings: Inhibition of effects of accelerator nerve stimulation in cats and rabbits by BS 100-141 and guanabenz. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.85
Pharmacology of guanfacine. Br J Clin Pharmacol (1980) 0.85
A comparative study of the cardiovascular reactivity in various hypertensive and in normotensive rats. Arzneimittelforschung (1971) 0.85
Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol (1985) 0.84
[Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)]. Arzneimittelforschung (1979) 0.84
Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts. Basic Res Cardiol (1998) 0.84
Pertussis toxin treatment does not inhibit the effects of the potassium channel opener BRL 34915 on rat isolated vascular and cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.83
Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration. Toxicol Appl Pharmacol (2004) 0.82
Intensity dependence of auditory evoked cortical potentials in migraine families. Pain (2000) 0.81
Cardiovascular actions of DPI 201-106, a novel cardiotonic agent. J Cardiovasc Pharmacol (1986) 0.81
Concentration of volatile fatty acids in digesta samples obtained from healthy cows and cows with cecal dilatation or dislocation. Am J Vet Res (1999) 0.81
Transplantation-induced endothelial dysfunction as studied in rat aorta allografts. Transplantation (2001) 0.81
Interaction of DPI 201-106 with cardiac glycosides. J Cardiovasc Pharmacol (1989) 0.81
Minimally invasive saphenous vein harvesting for coronary artery bypass grafting--comparison of three less invasive methods. Med Sci Monit (2001) 0.81
Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart. Am J Cardiol (1987) 0.81
Functional and morphologic assessment of saphenous veins harvested with minimally invasive techniques using a modified laryngoscope. Heart Surg Forum (2000) 0.80
The prevention and reversal of digoxin intoxication with specific antibodies. Am Heart J (1978) 0.80
Topical application of synthetic pyrethroids to cattle as a source of persistent environmental contamination. J Environ Sci Health B (1997) 0.79
SDZ RAD inhibits cold ischemia-induced vascular remodeling. Transplant Proc (1999) 0.79
[Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)]. Arzneimittelforschung (1979) 0.79
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat. Blood Press (1993) 0.78
An in vitro study on spontaneous myometrial contractility in the cow during estrus and diestrus. Anim Reprod Sci (2002) 0.78
Animal pharmacology of guanfacine. Am J Cardiol (1986) 0.78
Endothelial dysfunction and denudation in rat aortic allografts. Arterioscler Thromb Vasc Biol (2001) 0.77
Effects of ketanserin and DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter in vivo. Br J Pharmacol (2002) 0.77
Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstriction. J Pharm Pharmacol (1983) 0.77
Reduction of myocardial myoglobin in bovine dilated cardiomyopathy. J Mol Cell Cardiol (1997) 0.77
Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects. Clin Exp Hypertens A (1982) 0.76
The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats. J Pharm Pharmacol (1979) 0.76
Dopamine receptor mediated inhibition by bromocriptine of accelerator nerve stimulation effects in the pithed cat [proceedings]. Br J Pharmacol (1978) 0.75
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75
[The treatment of digitalis poisoning with antibiotics (author's transl)]. Z Kardiol (1980) 0.75
A study of the long-term effectiveness of education provided to medical students by teaching associate simulated patients. Proc Annu Conf Res Med Educ (1983) 0.75
Experimental heart transplantation: effect of cyclosporine on expression and activity of metzincins. Swiss Med Wkly (2009) 0.75
The effects of the beta-adrenoceptor blocking agent LL 21-945 on renal hypertensive (Grollman) rats. Arch Int Pharmacodyn Ther (1976) 0.75
A comparison of instructional techniques: internal-external vs external only. Annu Conf Res Med Educ (1979) 0.75
Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205-930. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.75
[Cognitive and psychomotor performance following isoflurane, midazolam/alfentanil and propofol anesthesia. A comparative study]. Anaesthesist (1992) 0.75
The effectiveness of digoxin-specific F(ab')2-antibody fragments in the treatment of digitoxin poisoning: experimental investigations in the cat. Eur J Clin Invest (1980) 0.75
Pharmacological actions of DPN 205-734, a novel cardiotonic agent. J Cardiovasc Pharmacol (1988) 0.75
Potentiating paired stimulation of cardiac muscle in vitro as positive inotropic reference standard. J Pharmacol Methods (1986) 0.75
Effects on blood lipids and body weight in high risk men of a practical exercise program. Atherosclerosis (1983) 0.75
[Species differences in cardiac sodium channels]. Schweiz Arch Tierheilkd (2000) 0.75
Perineal cryosurgery of prostate cancer. Urology (1981) 0.75
[Antibody treatment of digoxin intoxication in a patient with renal failure (author's transl)]. Dtsch Med Wochenschr (1979) 0.75
Cell culture in nephrotoxicity testing. Toxicol Lett (1990) 0.75
Inhibition of positive chronotropic effects of PGE2 by alinidine. Eur J Pharmacol (1982) 0.75
[Blood pressure effects of noradrenaline and angiotensin in hypertensive and normotensive rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
Suicidal digoxin poisoning: conventional treatment and antibody therapy. Klin Wochenschr (1982) 0.75
[Influence of ergotamine on humoral and neuronal effects in the cat nictitating membrane and spleen]. Helv Physiol Pharmacol Acta (1967) 0.75
[Mechanism of the hypertensive effect of heptaminol on the conscious dog]. Arzneimittelforschung (1972) 0.75
[An operative procedure for preparing carotid loops in dogs and their application for direct blood pressure determination]. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 0.75
Positive inotropic and electrophysiological effects of APP 201-533 can be explained by an increase of cardiac cyclic AMP. J Cardiovasc Pharmacol (1985) 0.75
Identification of cardiotonic sodium channel activators by potassium depolarization in isolated guinea-pig atria. J Pharmacol Methods (1990) 0.75
The effects of ergot compounds on the release of noradrenaline and prostaglandins from the isolated perfused cat spleen during nerve stimulation. Postgrad Med J (1976) 0.75
Heart failure and Ca++ activation of the cardiac contractile system: hereditary cardiomyopathy in hamsters (BIO 14.6), isoprenaline overload and the effect of APP 201-533. Basic Res Cardiol (1987) 0.75